Alcon (ALC) vs Warby Parker (WRBY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Warby Parker (WRBY) has outperformed Alcon (ALC) over the past year, gaining 1.4% versus a loss of 17.5%. Over five years, ALC leads with a -19.1% price change compared with -54.4% for WRBY. Alcon is the larger company by market cap ($30.90 billion vs $3.07 billion), about 10.1 times the size, while Warby Parker is growing revenue faster (+13.0% vs +4.9%).
On valuation, Alcon trades at a lower forward P/E (16.1x vs 40.4x for Warby Parker). Alcon pays a dividend yielding 0.55%, while Warby Parker does not currently pay one. Alcon converts more of its revenue into profit, with a net margin of 9.4% versus 0.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALC | WRBY |
|---|---|---|
| Share price | $63.93 | $24.85 |
| Market cap | $30.90B | $3.07B |
| 1-day change | +1.27% | -0.40% |
| YTD return | -19.90% | +14.50% |
| 1-year return | -17.53% | +1.42% |
| 5-year return | -19.08% | -54.43% |
| P/E ratio (TTM) | 48.43 | 414.17 |
| Forward P/E | 16.12 | 40.42 |
| EPS (TTM) | $1.32 | $0.06 |
| Dividend yield | 0.55% | 0.00% |
| Annual dividend | $0.353 | $0.00 |
| Revenue (latest FY) | $10.40B | $871.90M |
| Revenue growth (YoY) | +4.94% | +13.04% |
| Net income (latest FY) | $980.00M | $1.64M |
| Gross margin | 55.24% | 53.97% |
| Operating margin | 13.08% | -0.61% |
| Net margin | 9.42% | 0.19% |
| 52-week high | $87.64 | $31.00 |
| 52-week low | $61.84 | $14.96 |
| Distance from 52-week high | -27.05% | -19.84% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +30.69% | +22.57% |
| Average volume | 1.85M | 2.87M |
| Shares outstanding | 483.40M | 108.24M |
| Employees | 25,000 | 2,275 |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alcon is about 10.1 times larger than Warby Parker by market value ($30.90B vs $3.07B).
- WRBY has outperformed ALC by 19.0 percentage points over the past year.
- Warby Parker trades at a higher earnings multiple (414.2x vs 48.4x trailing P/E).
- Alcon is more profitable, keeping 9.4 cents of every revenue dollar as net income versus 0.2 cents for Warby Parker.
- Warby Parker grew revenue faster in its latest fiscal year (+13.04% vs +4.94%).
About Alcon
ALC stock →Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide.
Health Care · Ophthalmic Goods · 25,000 employees
About Warby Parker
WRBY stock →Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada.
Health Care · Ophthalmic Goods · 2,275 employees
ALC vs WRBY FAQ
Which is bigger, Alcon or Warby Parker?
Alcon (ALC) is larger, with a market capitalization of $30.90B compared with $3.07B for Warby Parker (WRBY).
Which stock has performed better over the past year, ALC or WRBY?
WRBY returned +1.42% over the past 12 months, compared with -17.53% for ALC (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ALC or WRBY?
ALC has the lower trailing P/E at 48.4, versus 414.2 for WRBY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Alcon or Warby Parker?
Alcon pays a dividend yielding 0.55%, while Warby Parker does not currently pay a regular dividend.
Are Alcon and Warby Parker in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.